Cardiology Updates Rosemont

Rosemont, IL | November 3, 2020

Donald E. Stephens Convention Center


The following financial relationships have been disclosed by faculty:  

Financial Disclosures

Peter Libby, MD
No financial disclosures

Other Disclosures

John D. Fisher, MD (Peer Reviewer, session "Dual Therapy with Low-Dose Anticoagulation and Aspirin") is a consultant for Medtronic, Inc. 

Peter Libby, MD has disclosed that he declines all personal compensation from all pharma or device companies. He has additionally disclosed the following competing interests: Grant/Research support: Novartis; Unpaid Consultant/Research:  Amgen, AstraZeneca, Esperion Therapeutics, Ionis Pharmaceuticals, Kowa Pharmaceuticals, Novartis, Pfizer, Sanofi-Regeneron, and XBiotech, Inc; Unpaid Scientific Advisory Board: Amgen, Covidia Therapeutics, DalCor Pharmaceuticals, IFM Therapeutics, Kowa Pharmaceuticals, Olatec Therapeutics, Medimmune, Novartis, XBiotech, Inc.

All non-faculty contributors to planning, development, editing and review of content have disclosed no relevant financial relationships.